National Cancer Center, Japan

This study is testing a new combination of two existing cancer drugs to treat a rare and aggressive skin cancer called cutaneous angiosarcoma. It will enroll 38 patients in Japan whose cancer cannot be removed by surgery. The goal is to see if the drug combo is more effective at …

This trial is testing an experimental drug called E7090 for people with advanced or returning solid tumors that have specific changes in a gene called FGFR. It is for patients whose cancer has stopped responding to standard treatments or for whom no standard treatments are availa…

This study is testing a new drug called enfortumab vedotin for people with advanced small bowel cancer that has stopped responding to standard chemotherapy. The drug is designed to target a specific protein found on many of these cancer cells. Researchers will give the drug to ab…